Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.95
+0.09 (0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
14.73
-0.22 (-1.47%)
After-hours: Mar 9, 2026, 5:58 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.30 billion as of March 9, 2026. Its market cap has increased by 87.01% in one year.
Market Cap
2.30B
Enterprise Value
2.20B
1-Year Change
87.01%
Ranking
Category
Stock Price
$14.95
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.30B, a decrease of -51.79%. That is a compound annual growth rate of -10.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |
| Tango Therapeutics | 2.42B |
| Immunome | 2.38B |
| Disc Medicine | 2.33B |
| Ocular Therapeutix | 2.24B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |